1. Home
  2. >
  3. Results
  4. >
  5. Deliverables

Work package 1: Programme management and coordination

Deliverable 1.5 Legal and Ethics Policy Paper, September 2018

Published: 24/09/2018

Grant agreement, November 2016

Published: 01/03/2017

Deliverable 1.2 Establishment of Governing Board, August 2019

Published: 01/03/2017, Updated: 13/08/2019

Deliverable 1.8 Establishment of Stakeholder Forum and Advisory Board

Published: 27/09/2017

Work package 2: Knowledge hub

Deliverable 2.2 Strategy for the communication and dissemination of HBM4EU results, March 2017

Published: 31/03/2017

Deliverable 2.15 2021 Programme of training activities, materials and capacity building mechanisms

Published: 21/12/2020

Deliverable 2.3 2018 Strategy for the communication and dissemination of HBM4EU results

Published: 09/10/2017

Deliverable 2.13 2021 Strategy for the communication and dissemination of HBM4EU results

Published 14/04/2021

Deliverable 2.4 2018 Programme of training activities, materials and capacity building mechanisms

Published: 27/11/2017

D2.17 Second Report on the content and use of the online library

Published: 01/12/2021

Deliverable 2.7 Online library: content and use, November 2018

Published: 02/11/2018

Deliverable 2.6 First review of training methods

Published: 12/03/2019

Deliverable 2.9 Summary report on helpdesk activities

Published: 05/08/2019

Deliverable 2.8 2019 Programme of training activities, materials and capacity building mechanisms

Published: 08/10/2019

Work package 4: Prioritisation and input to the annual work plan

Deliverable Report 4.4 - First report on the stakeholder consultation and the mapping of needs

Published: 08/08/2018

Deliverable 4.5 Second list of HBM4EU priority substances and Chemical Substance Group Leaders for 2019-2021

Published: 03/09/2018

Deliverable 4.6 Scoping documents for the second round priority substances

Published: 25/03/2019

Deliverable 4.7 Scoping documents for 2020 - 2nd set of priority substances - Update of policy questions and related HBM4EU activities

Published: 15/10/2019

Additional Deliverable 4.3 Improvement of the strategy for the prioritisation of substances under HBM4EU

Published: 03/03/2020

Deliverable 4.9 Scoping documents for 2021 for the first and second second round HBM4EU priority substances

Published: 11/12/2020

Additional Deliverable 4.2 Report of the citizens’ focus groups

Published: 19/02/2021

Deliverable 4.10 2nd Report on stakeholder consultation and mapping of needs

Published: 19/08/2021

Deliverable 4.1 Template for the submission of rapid requests, May 2017

Published: 18/05/2017

Deliverable 4.2 Scoping documents on HBM4EU priority substances for 2018, June 2017

Work package 5: Translation of results into policy

Additional Deliverable 5.5 Generating indicators incorporating HBM-GV – first visualisation examples

Published: 19/08/2021

Deliverable 5.4 A (phased) plan for action: from Human Biomonitoring to targeted policy action - Report of Case Study 1 – phthalates and bisphenols

Published: 05/04/2019

Deliverable 5.9 3rd substance specific derivation of EU-wide health-based guidance values

Published: 01/12/2021

Additional Deliverable 5.9 Timelines of opportunity: How HBM4EU can support chemicals management policy needs

Published: 14/08/2020

Deliverable 5.5 Human biomonitoring in risk assessment: 2nd set of examples on the use of HBM in risk assessments of HBM4EU priority chemicals

Published: 09/07/2019

Additional Deliverable 5.2 Reporting for first set of substances

Published: 22/10/2019

Additional Deliverable 5.3 Case-study report on HBM-indicators

Published: 27/12/2019

Additional Deliverable 5.4 Reporting for first and second set of substances

Published: 23/12/2020

Deliverable 5.15 Derivation of HBM guidance values (HBM-GVs) for Cadmium: for the general population and for workers

Published: 14/04/2021

Deliverable 5.6 Derivation of Human Biomonitoring Guidance Values (HBM-GVs) for selected phthalates

Published: 14/04/2021

Work package 6: Sustainability and capacity building

Deliverable 6.2 Revised set of key indicators

Published: 13/08/2019

Deliverable 6.5 Sustainability of HBM4EU in the future and related operational architecture concept: first report

Published: 13/08/2019

Additional Deliverable 6.2 Results of the interaction and surveys with the Environment Protection Agency network and the National Reference Centre on Environment & Health

Published: 05/08/2020

Additional Deliverable 6.3 Legacy of HBM4EU for a new partnership

Published: 05/08/2020

Deliverable 6.4 Revised report on national needs, objectives of a long-term HBM4EU inventory of funding mechanisms and recommendations for a sustainable HBM initiative in Europe and its organisation

Published: 12/07/2021

Deliverable 6.6 HBM in Europe: legacy of HBM4EU and frameworks for medium- and long-term sustainability

Published: 01/12/2021

Deliverable 6.1 First set of key indicators for HBM4EU, June 2017

Published: 26/06/2017

Additional deliverable 6.1 Preliminary Report on different options for a sustainable EU HBM and feedback from different institutions

Published: 09/07/2019

Deliverable 6.3 Consultation on a sustainable HBM initiative in Europe

Published: 28/01/2019

Work package 7: Survey design and fieldwork preparation

Deliverable 7.6 - 2nd prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling

Published: 12/07/2021 (2nd update)

Deliverable 7.4 1st material for communication to participants, including informed consent

Published: 17/07/2018

Deliverable 7.5 Report on ongoing activities and existing data and data gaps for the 2nd prioritised substances

Published: 25/01/2019

Additional deliverable 7.2 Literature research and concept for a sample quality study on impact of thawing and freezing on integrity of human samples for selected 1st and 2nd priority substances

Published: 28/01/2019

Deliverable 7.7 - 2nd set of materials for communication to participants, including informed consent

Published: 10/04/2019

Additional deliverable 7.1 Upgrade of the strategy for human sample exchange, including SOPs

Published: 06/09/2019

Deliverable 7.8 Report on ongoing activities and existing data and data gaps

Published: 21/12/2020

Deliverable 7.9 Overall report on WP7 documents for survey design, Study protocols, SOPs and Guidelines, and questionnaires

Published: 23/06/2021

Deliverable 7.1 Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM

Published: 19/12/2017

Deliverable 7.2 Strategy and SOPs for human sample exchange, including ethical demands

Published: 01/04/2020

Work package 8: Targeted field work surveys and alignment at EU level

Additional Deliverable - Cr fact sheets ; French, Finnish, German, Italian, Portuguese, Dutch and Polish

Published: 09/08/2018

Deliverable 8.9 Report on progress targeted occupational studies

Update published: 01/12/2021

Deliverable 8.3 First report on targeted new fieldwork study results

Published: 29/08/2018

Deliverable 8.4 Initial report on strategies adopted to align studies across Europe

Published: 03/09/2018

Deliverable 8.2 First report on biobank activities, August 2018

Published: 13/11/2018

Deliverable 8.5 Initial Report on Occupational Studies

Published: 05/04/2019

Deliverable 8.7 Second report on targeted new fieldwork and results

Published: 27/12/2019

Deliverable 8.6 Second report on biobank activities

Published: 23/01/2020

Additional Deliverable 8.4 Detailed research plan for the occupational diisocyanate and E-waste study

Published: 09/04/2020

Additional deliverable 8.1 Report on access to occupational data

Published: 27/06/2017

Work package 9: Laboratory analysis and quality assurance

Deliverable 9.3 Database of candidate laboratories for the 1st prioritisation round of substances

Published: 14/03/2018

Deliverable 9.4 The Quality Assurance/Quality Control Scheme in the HBM4EU project

Published: 03/11/2017

Additional Deliverable 9.1 General guidance for new method development within HBM4EU and role of task 9.3 therein

Published: 17/07/2018

Deliverable 9.6 - Databases of candidate laboratories for the 2nd prioritisation round of substances

Published: 04/07/2019

Deliverable 9.5 Prioritised list of biomarkers, matrices and analytical methods for the 2nd prioritisation round of substances

Update published: 01/12/2020

Additional Deliverable 9.6 Partners performing chemical analyses of substances on the 1st priority list in the aligned studies

Published: 14/08/2020

Deliverable 9.7 First report on analytical results and new methods development

Published: 08/10/2019

Additional Deliverable 9.3 Report on activities in the analytical phase

Published: 27/12/2019

Additional Deliverable 9.2 - Survey of tentative prices for biomarker analyses

Published: 12/04/2019

Deliverable 9.9 Second report on analytical results and new methods developed

Published: 01/12/2021

Work package 10: Data management and analysis

Deliverable 10.4 1st annual list of exposure distributions and/or European reference values

Published: 30/01/2019

Deliverable 10.5 Statistical Analysis Plan

Published: 01/03/2019

Deliverable 10.6 Second annual list of exposure distributions and/or European Reference Values

Published: 03/04/2020

Deliverable 10.7 Revised Data Management Plan (DMP)

Published: 11/12/2020

Deliverable 10.10 Statistical analysis plan for the co-funded studies of WP8

Published: 21/12/2020

Deliverable 10.1 Data Management Plan, July 2017

Published: 01/08/2017

Annex to Deliverable 10.1 Data Policy, July 2017

Published: 01/08/2017

Deliverable 10.2 Statistical Analysis Plan

Published: 03/01/2018

Work package 11: Linking HBM, health surveys and registers

Deliverable 11.2 - Report on workshop about opportunities and obstacles for linking HBM and health studies

Published: 15/02/2019

Deliverable 11.3 - Report on opportunities and obstacles of combining HBM and health studies, availability of health studies with biological samples, availability of administrative registers, and guidelines for combining HBM and health studies for the 2nd prioritisation round of substances

Published: 12/06/2019

Additional Deliverable 11.3 Selection of feasibility studies for linking HBM and health studies, and linking to administrative data sources

Published: 10/01/2019

Deliverable 11.4 Second update on the report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelines

Published: 18/10/2021

Deliverable 11.5 Final evaluation report from the feasibility studies

Published: 01/12/2021

Additional Deliverable 11.1 How can the results from BRIDGE Health be incorporated to the work of HBM4EU?

Published: 28/09/2017

Additional Deliverable 11.2 Criteria for feasibility studies

Published: 28/09/2017

Deliverable 11.1 Report on opportunities and obstacles of combining HBM and health studies, availability of health studies with biological samples, availability of administrative registers, and guidelines for combining HBM and health studies

Published: 29/06/2018

Work package 12: From HBM to exposure

Deliverable 12.1 Review paper on PBTK/D models for the 1st set of priority compounds

Published: 12/12/2018

Additional Deliverable 12.9 Report on biochemical/metabolic interactions among mixture components based on computational modelling

Published: 27/05/2021

Deliverable 12.3 Biological half-life and internal dosimetry of the 1st set of priority compounds

Published: 28/01/2019

Deliverable 12.5: Risk characterisation of the 1st set of prioritised substances using external exposure estimated from HBM data: a methodological approach

Additional deliverable 12.4 - Conceptual design of the integrated computational platform

Published: 15/02/2019

Additional Deliverable AD12.6 “Optimised algorithms for reverse dosimetry“

Published: 13/06/2019

Deliverable 12.4 Report on estimation of relevant tissue and biological fluid doses of 1st set of priority compounds in the EU population using refined PBTK modelling

Published: 13/08/2019

Additional Deliverable 12.3 Exposure model testing results

Published: 14/08/2019

Additional Deliverable 12.5 Delivery of exposure estimates for the 1st set of prioritised substances based on HBM data

Published: 03/09/2019

Additional Deliverable 12.7 Report on optimised sampling schemes for rapidly metabolised and persistent/biocumulative substances

Published: 27/12/2019

Work package 13: Establishing exposure health relationships

Deliverable 13.3 - Inventory of available samples and data collected from existing cohorts and preliminary results on exposure- response associations for 1st list of priority substances

Published: 27/02/2019

Deliverable 13.5 Identified gaps for the establishment of AOPs and required studies

Published: 09/07/2019

Deliverable 13.4 Report on AOPs of priority substances

Published: 11/06/2020

Additional Deliverable 13.7 Draft guidance and recommendations for risk assessors and policymakers on the use of mechanistic toxicology data and AOPs

Published: 19/08/2021


The file contains tables with contacts to LEADERS (Table 1) who should coordinate discussions within chemical groups and OTHER PARTNERS (Table 2) who contributes with relevant chemical expertise. Published: 04/05/2018

Deliverable 13.1 Criteria for the selection of cohort studies, June 2017

Published: 20/07/2017

Deliverable 13.2 Template for AOP update report for selected priority substances

Published: 29/06/2018

Work Package 14: Effect biomarkers

Deliverable 14.4 Report on results of the selected biomarkers of combined effect [Proof of concept]

Published: 15/11/2018

Additional Deliverable 14.4 First report on the state of development of new biomarkers of effect

Published: 28/01/2019

Deliverable 14.3 Report on available biomarkers of effect of utility in human epidemiological studies for the 1st set of prioritised substances

Published: 30/01/2019

Additional Deliverable 14.3 - WP14 - WP13 Interaction: Delineation of AOPs for the selection of effect biomarkers in the HBM4EU aligned studies Bisphenol A as a case-study

Published: 10/04/2019

Additional Deliverable 14.5 Report on the 2nd Granada Workshop: Implementing Effect Biomarkers

Published: 10/07/2019

Deliverable 14.5 Selection criteria and inventory of effect biomarkers for the 2nd set of substances

Published: 12/03/2020

Additional Deliverable 14.6 Report on the state of development of Task 14.3: Identification of needs for the implementation of both classical and new biomarkers of effect and decision criteria for their validation

Published: 26/11/2020

Deliverable 14.7 Guidelines for the validation of biomarkers of effect: implementing quality assurance, trueness, precision, and accuracy as well as the availability of quality control measures by qualified laboratories

Published: 14/04/2021

Deliverable 14.1 Criteria for prioritisation of biomarkers of effect

Published: 02/10/2017

Additional Deliverable 14.2 Granada Workshop: Effect biomarkers & establishing exposure and health relationships

Published: 08/08/2018

Work package 15: Mixtures, HBM and human health risks

Additional Deliverable 15.7 Joint survey of pesticides: details of approach and contributions

Published: 22/10/2019

Deliverable 15.4 Report on approaches to identify mixture health effects

Published: 03/03/2020

Deliverable 15.1 Information needs from policy makers translated in terms of functionality of HBM mixture information

Published: 23/01/2020

Deliverable 15.5 Case study reports on mixture health effects

Published: 12/07/2021

Additional Deliverable 15.3 HBM mixture database description and proposal statistical analysis plan

Published: 03/01/2018

Deliverable 15.3 Report real-life exposure profiles from re-analysis of existing HBM mixture data

Published: 28/01/2019

Additional Deliverable 15.1 Plan for development of case studies

Published: 21/03/2019

Work package 16: Emerging chemicals

Additional Deliverable 16.4 Emerging Substances

Published: 21/12/2018

Deliverable 16.2 Workflow for screening emerging chemicals

Published: 28/01/2019

Additional Deliverable 16.2 - Emerging chemicals framework

Published: 15/02/2019

Additional Deliverable 16.5 Updated prioritised list of known emerging chemicals. Updated list of known chemicals (parent compounds or metabolites) to be considered as exposure markers of emerging concern

Published: 07/10/2019

Deliverable 16.4 Emerging exposure markers database - Reference Mass Spectral Libraries for Suspect Screening of Chemicals of Emerging Concern

Published: 17/06/2021

Deliverable 16.1 Prioritised list of known emerging chemicals

Published: 03/01/2018

Additional Deliverable 16.1 Screening methods inventory

Published: 03/01/2018

Additional Deliverable 16.3 Direct effect based approaches applied to the screening of emerging substances

Published: 03/01/2018